BELLICUM PHARMACEUTICALS INC's ticker is BLCM and the CUSIP is 079481107. A total of 81 filers reported holding BELLICUM PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 1.15 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $77,000 | +22.2% | 60,000 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $63,000 | -38.2% | 60,000 | 0.0% | 0.00% | -25.0% |
| Q2 2019 | $102,000 | -49.5% | 60,000 | 0.0% | 0.00% | -50.0% |
| Q1 2019 | $202,000 | +15.4% | 60,000 | 0.0% | 0.01% | +14.3% |
| Q4 2018 | $175,000 | -52.7% | 60,000 | 0.0% | 0.01% | -46.2% |
| Q3 2018 | $370,000 | -16.5% | 60,000 | 0.0% | 0.01% | -23.5% |
| Q2 2018 | $443,000 | +12.4% | 60,000 | 0.0% | 0.02% | +13.3% |
| Q1 2018 | $394,000 | -22.0% | 60,000 | 0.0% | 0.02% | -21.1% |
| Q4 2017 | $505,000 | -27.1% | 60,000 | 0.0% | 0.02% | -24.0% |
| Q3 2017 | $693,000 | -1.1% | 60,000 | 0.0% | 0.02% | -3.8% |
| Q2 2017 | $701,000 | -5.3% | 60,000 | 0.0% | 0.03% | -10.3% |
| Q1 2017 | $740,000 | -9.4% | 60,000 | 0.0% | 0.03% | -17.1% |
| Q4 2016 | $817,000 | -31.6% | 60,000 | 0.0% | 0.04% | -23.9% |
| Q3 2016 | $1,194,000 | +53.5% | 60,000 | 0.0% | 0.05% | +43.8% |
| Q2 2016 | $778,000 | +38.7% | 60,000 | 0.0% | 0.03% | +33.3% |
| Q1 2016 | $561,000 | -53.9% | 60,000 | 0.0% | 0.02% | -45.5% |
| Q4 2015 | $1,216,000 | +39.4% | 60,000 | 0.0% | 0.04% | +41.9% |
| Q3 2015 | $872,000 | -31.7% | 60,000 | 0.0% | 0.03% | -32.6% |
| Q2 2015 | $1,276,000 | -8.2% | 60,000 | 0.0% | 0.05% | -16.4% |
| Q1 2015 | $1,390,000 | +0.6% | 60,000 | 0.0% | 0.06% | -15.4% |
| Q4 2014 | $1,382,000 | – | 60,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|